Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

NCT01596530 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped All AstraZeneca sponsored clinical trials of AZD8931 have been halted

Conditions

Breast Neoplasm

Interventions

DRUG: Drug-AZD8931
DRUG: Drug-Placebo

Sponsor

AstraZeneca